Australia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Australia

The Australian medicaments containing hormones market stood at $X in 2022, growing by X% against the previous year. Over the period under review, consumption showed a resilient increase. Medicaments containing hormones consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Medicaments Containing Hormones Production in Australia

In value terms, medicaments containing hormones production stood at $X in 2022 estimated in export price. Over the period under review, production recorded a strong increase. The pace of growth was the most pronounced in 2015 with an increase of X%. Over the period under review, production hit record highs at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports from Australia

In 2022, approx. X tons of medicaments containing hormones but not antibiotics were exported from Australia; with a decrease of X% against the previous year. In general, exports, however, continue to indicate a significant expansion. The most prominent rate of growth was recorded in 2018 when exports increased by X%. The exports peaked at X tons in 2021, and then dropped rapidly in the following year.

In value terms, medicaments containing hormones exports reduced rapidly to $X in 2022. Over the period under review, exports, however, saw prominent growth. The pace of growth appeared the most rapid in 2018 when exports increased by X% against the previous year. The exports peaked at $X in 2019; however, from 2020 to 2022, the exports remained at a lower figure.

Exports by Country

The United States (X tons) was the main destination for medicaments containing hormones exports from Australia, with a X% share of total exports. Moreover, medicaments containing hormones exports to the United States exceeded the volume sent to the second major destination, China (X tons), fivefold. The third position in this ranking was taken by New Zealand (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to the United States amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and New Zealand (X% per year).

In value terms, the United States ($X) remains the key foreign market for medicaments containing hormones but not antibiotics exports from Australia, comprising X% of total exports. The second position in the ranking was taken by Saudi Arabia ($X), with a X% share of total exports. It was followed by China, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Saudi Arabia (X% per year) and China (X% per year).

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, shrinking by X% against the previous year. In general, the export price showed a abrupt decrease. The pace of growth appeared the most rapid in 2015 when the average export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the average export prices failed to regain momentum.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while the average price for exports to China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%).

Medicaments Containing Hormones Imports

Imports into Australia

In 2022, purchases abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fifth year in a row after two years of decline. Over the period under review, imports enjoyed a remarkable increase. The pace of growth was the most pronounced in 2015 when imports increased by X% against the previous year. Imports peaked in 2022 and are likely to see steady growth in the near future.

In value terms, medicaments containing hormones imports fell rapidly to $X in 2022. Overall, imports enjoyed significant growth. The most prominent rate of growth was recorded in 2015 when imports increased by X%. Over the period under review, imports reached the maximum at $X in 2021, and then shrank sharply in the following year.

Imports by Country

In 2022, China (X tons) constituted the largest supplier of medicaments containing hormones to Australia, accounting for a X% share of total imports. Moreover, medicaments containing hormones imports from China exceeded the figures recorded by the second-largest supplier, the UK (X kg), eightfold.

From 2012 to 2022, the average annual rate of growth in terms of volume from China stood at X%.

In value terms, China ($X) and the UK ($X) constituted the largest medicaments containing hormones suppliers to Australia.

In terms of the main suppliers, China, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review.

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2022, waning by X% against the previous year. In general, the import price, however, saw a buoyant expansion. The most prominent rate of growth was recorded in 2021 when the average import price increased by X%. Over the period under review, average import prices hit record highs at $X per ton in 2018; however, from 2019 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for China stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the Netherlands (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :